Hanall Biopharma
한올바이오파마KRX: 009420· Fiscal year 2025· hanall.co.kr ↗
Average salary
$61.7K
₩82.1M
▲ 4.3% vs 2024
Employees
315
▼ 0.9% vs 2024
Average tenure
Not disclosed
Estimated take-home of this pay:$4.1K / monthCalculate →
Workplace
Women's pay (men = 100)81
Women among staff33%
Contract staff4.4%
Recent official filings
- 2026-11-13Quarterly report (2026.09)
- 2026-10-28Preliminary earnings (consolidated)
- 2026-08-14Half-year report (2026.06)
- 2026-07-31Investor relations (IR) event
- 2026-07-29Preliminary earnings (consolidated)
- 2026-05-28Investor relations (IR) event
Quick read
- Average pay is 34% above the median of the companies we track.
- Average pay rose 4.3% from 2024.
- Headcount shrank by 3 (0.9%) from 2024.
- Ranks #19 of 238 Healthcare & Pharma companies in this country by pay.
- Revenue grew 11.7% year over year.
- Revenue has grown two years in a row.
- Operating loss of $685.8K in 2025.
Last 3 years
Revenue
Operating income
See the share price on Naver Finance ↗
Investor metrics
2025
- Revenue per employee
- $368.9K
- Net profit per employee
- -$13.2K
- Operating margin
- -0.6%
- Net margin
- -3.6%
- ROE
- -3.4%
- Debt-to-equity
- 39.3%
- Equity ratio
- 71.8%
Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.